Position in ZTS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,093,278
+$664,447 QoQ
Shares Held
15,214
+478.0% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#622
of 1,408 holders
Holding Since
Sep 2020
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Derivatives in ZTS
reported options exposure · as of Jun 30, 2022CallValue
$0
CallShares
0
PutValue
$223,457
PutShares
1,300
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Maven Securities LTD holds $1,542,278 across 3 Drug Manufacturers - Specialty & Generic names. ZTS ranks #1 (70.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
This page
|
15,214 | $1,093,278 | |
| 2 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
25,000 | $449,000 | |
| 3 | 1,244,100 | $0 |
All Filings in ZTS
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,093,278 | 15,214 | Shares | Defined | 2026-08-14 | |
| 2024-12-31 | $428,831 | 2,632 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $200,459 | 1,026 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $230,395 | 1,329 | Shares | Defined | 2024-08-29 | |
| 2022-06-30 | $223,457 | 1,300 | Put | Defined | 2022-08-15 | |
| 2020-12-31 | $303,858 | 1,836 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $332,559 | 2,011 | Shares | Defined | 2020-11-13 | |
| No filing history on record for this holder in this stock. | ||||||